NCT07892898

Brief Summary

A prospective comparative clinical trial of postoperative delirium incidence in open versus laparoscopic nephrectomy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
134

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 19, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 23, 2026

Completed
Last Updated

October 23, 2026

Status Verified

May 1, 2026

Enrollment Period

7 months

First QC Date

October 19, 2026

Last Update Submit

October 19, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of Postoperative Delirium

    The presence or absence of delirium will be assessed using the Confusion Assessment Method (CAM). For patients who screen positive via CAM, delirium severity will be graded using the Delirium Index (DI). The DI scores 7 domains from 0 (absent) to 3 (severe), with a total score range of 0 to 21 (higher scores indicate worse severity.

    Once daily on Postoperative Days (POD) 1, 2, and 3.

Secondary Outcomes (4)

  • Postoperative Pain Intensity at Rest and During Movement

    Postoperative Days (POD) 1, 2, and 3.

  • Cumulative Postoperative Analgesic Consumption

    Postoperative Days (POD) 1, 2, and 3.

  • Postoperative Functional Recovery Milestones

    From end of surgery up to hospital discharge (monitored daily, up to an estimated 14 days).

  • Intraoperative Hemodynamic and Anesthetic Depth Parameters

    Baseline (Pre-induction, T1), 45 minutes intraoperatively (T2), 90 minutes intraoperatively (T3), and 10 minutes before the end of surgery (T4).

Study Arms (2)

Open Nephrectomy

ACTIVE COMPARATOR

Patients undergo traditional open elective nephrectomy under standard general anesthesia. Postoperative analgesia includes regular IV ketorolac and morphine patient-controlled analgesia (PCA) for 48 hours

Procedure: Open Nephrectomy

Laparoscopic Nephrectomy

EXPERIMENTAL

Patients undergo laparoscopic elective nephrectomy under standard general anesthesia. Postoperative analgesia follows the identical standardized protocol (IV ketorolac + morphine PCA).

Procedure: Laparoscopic Nephrectomy

Interventions

Open nephrectomy

Open Nephrectomy

Laparoscopic Nephrectomy

Laparoscopic Nephrectomy

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • \- Patients scheduled to undergo elective nephrectomy for benign or malignant renal conditions.
  • American Society of Anesthesiologists (ASA) physical status classification I, II, or III.
  • New York Heart Association (NYHA) functional classification class I or II.

You may not qualify if:

  • Preoperative Mini-Mental State Examination (MMSE) score of 23 or less.
  • Documented history of dementia, neurological diseases, psychiatric illness, or active drug/psychotropic substance abuse prior to admission.
  • Preoperative hepatic encephalopathy grade III or IV.
  • Severe visual or hearing impairments that preclude effective patient communication.
  • Emergency nephrectomy procedures.
  • Inability or refusal to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Urology Department, Alexandria University Main Hospital

Alexandria, Alexandria Governorate, 112 OMAR L, Egypt

Location

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2026

First Posted

October 23, 2026

Study Start

January 1, 2026

Primary Completion

July 15, 2026

Study Completion

September 2, 2026

Last Updated

October 23, 2026

Record last verified: 2026-05

Locations